JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
J&J is repositioning its MedTech portfolio toward more innovative, faster-growing areas, most notably cardiovascular. Strategic acquisitions, including Shockwave in 2024 and Abiomed in 2022, have strengthened its presence, making it a leader across four of the largest and fastest-growing cardiovascular intervention markets. Reflecting this momentum, J&J's Cardiovascular sales increased 15.8% to reach $8.9 billion in 2025. J&J's MedTech business has improved in the last three quarters, driven by the acquired cardiovascular businesses, Abiomed and Shockwave, as well as Surgical Vision and wound closure in Surgery. Improvements in J&J's electrophysiology business also drove the growth. MedTech sales rose 4.3% on an organic basis in 2025. The MedTech segment is expected to continue seeing strong momentum in three focus areas: Cardiovascular, Surgery and Vision in the first quarter, backed by increased adoption of newly launched products across all three segments. However, the compa
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- This Healthcare Stock Barely Flinches During Market Sell-Offs [Yahoo! Finance]Yahoo! Finance
- Factbox-Global pharma companies that have publicly announced Trump drug pricing agreements [Yahoo! Finance]Yahoo! Finance
- Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030 [Yahoo! Finance]Yahoo! Finance
- Why Johnson & Johnson (JNJ) Is One of the Best Pharma Stocks to Invest in Now [Yahoo! Finance]Yahoo! Finance
- JNJ Stock's 60% Breakout: Why Wall Street is Torn [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website